SERUM SOLUBLE INTERLEUKIN-2 RECEPTOR IS ASSOCIATED WITH CLINICAL AND PATHOLOGICAL DISEASE STATUS IN HAIRY-CELL LEUKEMIA

Authors:
  • RMR MICK
    R MICK
  • JLJM LATTA
    JM LATTA
  • KDK DALY
    K DALY
  • MRMJ RATAIN
    MJ RATAIN
  • JVJW VARDIMAN
    JW VARDIMAN
  • HGHM GOLOMB
    HM GOLOMB

  • 15 November 1990
    • journal article
    • research article
    • Vol. 76  (10) , 1941-1945
    • PMID:1700727
Abstract
Hairy cell leukemia is a chronic lymphoproliferative disorder of B-cell lineage, whose malignant cells express the interleukin-2 (IL-2) receptor. A soluble form and the IL-2 receptor is released by these cells in culture, and the sera of patients with hairy cell leukemia contain elevated levels of this soluble receptor. Four hundred twenty-seven serum samples from 101 patients were analyzed for soluble IL-2 receptor (sIL-2R). The clinical status of patients appeared to be associated with the serum level of sIL-2R. The hairy cell index (a measure of tumor cell burden) was correlated with the square root of the serum sIL-2R level (r = .77). Improved clinical status was associated with decreasing serum sIL-2R levels, whereas disease relapse was associated with increasing levels. Notably, every patient who responded to therapy had a decline in serum sIL-2R level, and every patient with disease progression had an increase in serum sIL-2R level. This phenomenon was observed for several different treatments, including standard-dose interferon, low-dose interferon, and deoxycoformycin. The predictive reliability of this test is currently being prospectively evaluated.

This publication has 12 references indexed in Scilit: